Comprehensive Cancer Center of Nevada

Las Vegas, Nevada 89169-3321

2 studies enrolling now · 19 studies all time

What they study most

Advanced Breast Cancer, Advanced Gastric Cancer, Advanced Malignant Solid Tumor, Advanced Solid Tumor, Advanced/Metastatic Non-Small Cell Lung Cancer, Anal Cancer, B-cell Lymphoma, Breast Adenocarcinoma, Breast Cancer, Breast Cancer Female, Breast Neoplasms, Cancer

Studies at this site

• A Study of CHS-114 (Tagmokitug) in Combination With Toripalimab and/or Other Treatments in Participants With Advanced Solid Tumors — Recruiting now
• Safety, PK, and Preliminary Efficacy of MBRC-101 in Advanced Refractory Solid Tumors — Recruiting now
• Phase 1b/2 Platform Study of Select Immunotherapy Combinations in Participants With Advanced Non-small Cell Lung Cancer (NSCLC) — Running, not enrolling
• A Study to Compare the Blood Levels and Safety of Tazemetostat in Participants With Advanced Cancer and Moderate/Severe Liver Impairment to Participants With Advanced Cancer and Normal Liver Function — Stopped early
• CAB-AXL-ADC Safety and Efficacy Study in Adult and Adolescent Patients With Sarcoma — Completed
• Ociperlimab With Tislelizumab and Chemotherapy in Participants With Untreated Metastatic Non-Small Cell Lung Cancer — Completed
• INCB050465 in Combination With Rituximab, Bendamustine and Rituximab, or Ibrutinib in Participants With Previously Treated B-Cell Lymphoma (CITADEL-112) — Completed
• Phase 1 Study of Oral TP-1454 — Completed
• Trial of H3B-6545, in Women With Locally Advanced or Metastatic Estrogen Receptor-positive, HER2 Negative Breast Cancer — Completed
• Study to Evaluate the Efficacy and Safety of TT-00420 (Tinengotinib) in Cholangiocarcinoma — Completed
• A Study to Compare Tivozanib Hydrochloride to Sorafenib in Participants With Refractory Advanced Renal Cell Carcinoma (RCC) — Completed
• A Study of Itacitinib (INCB039110) in Combination With Ibrutinib in Subjects With Relapsed or Refractory Diffuse Large B-Cell Lymphoma — Completed
• A Safety Trial of Nivolumab in Patients With Advanced or Metastatic Non-Small Cell Lung Cancer Who Have Progressed During or After Receiving At Least One Prior Chemotherapy Regimen — Completed
• Ibrutinib in Combination With Lenalidomide and Rituximab in Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma — Completed
• A Phase III Safety and Efficacy Study of L-Glutamine to Treat Sickle Cell Disease or Sickle βo-thalassemia — Completed
• A Continuation Study Using Sunitinib Malate For Patients Leaving Treatment On A Previous Sunitinib Study. — Completed
• Immune Monitoring on Sipuleucel-T — Completed
• Study to Compare the Effect of Ipilimumab Retreatment With That of Chemotherapy in Advanced Melanoma — Stopped early
• MEDI-522 in the Treatment of Patients With Metastatic Androgen-Independent Prostate Cancer — Completed